1. Clinical significance of aberrant cyclin-dependent kinase-like 2 methylation in hepatocellular carcinoma
    Ye Zhou et al, 2019, Gene CrossRef
  2. Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation
    Rui-kun Zhang et al, 2021, BMC Medical Genomics CrossRef
  3. The effect of key DNA methylation in different regions on gene expression in hepatocellular carcinoma
    Yu-Xian Liu et al, 2022, Molecular Omics CrossRef
  4. Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients
    Jean M. Winter et al, 2022, Cancer Biomarkers CrossRef
  5. TRIM58 Interacts with Pyruvate Kinase M2 to Inhibit Tumorigenicity in Human Osteosarcoma Cells
    Peng Yuan et al, 2020, BioMed Research International CrossRef
  6. Expression of decitabine-targeted oncogenes in meningiomas in vivo
    Julian Canisius et al, 2022, Neurosurgical Review CrossRef
  7. Integrative analysis of gene expression and DNA methylation using unsupervised feature extraction for detecting candidate cancer biomarkers
    Myungjin Moon et al, 2018, Journal of Bioinformatics and Computational Biology CrossRef
  8. Luminescence Sensing for Qualitative and Quantitative Detection of 5-Methylcytosine
    Yushu Yuan et al, 2018, Analytical Chemistry CrossRef
  9. Essential amino acid metabolism-related molecular classification in triple-negative breast cancer
    Yajie Zhao et al, 2021, Epigenomics CrossRef
  10. TRIM proteins in hepatocellular carcinoma
    Kan Lu et al, 2022, Journal of Biomedical Science CrossRef
  11. The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years
    Song Zhang et al, 2021, Briefings in Bioinformatics CrossRef
  12. The translational values of TRIM family in pan-cancers: From functions and mechanisms to clinics
    Guo Zhao et al, 2021, Pharmacology & Therapeutics CrossRef
  13. Ubiquitination Links DNA Damage and Repair Signaling to Cancer Metabolism
    Seo-Young Koo et al, 2023, International Journal of Molecular Sciences CrossRef
  14. Pan-cancer illumination of TRIM gene family reveals immunology regulation and potential therapeutic implications
    Yueying Gao et al, 2022, Human Genomics CrossRef
  15. Differential Expression of Genes for Ubiquitin Ligases in Medulloblastoma Subtypes
    Jerry Vriend et al, 2019, The Cerebellum CrossRef
  16. Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma
    Rui Xu et al, 2019, BioMed Research International CrossRef
  17. AUF1 Promotes Proliferation and Invasion of Thyroid Cancer via Downregulation of ZBTB2 and Subsequent TRIM58
    Xin Du et al, 2021, Frontiers in Oncology CrossRef
  18. TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway
    Naizhi Sun et al, 2023, World Journal of Surgical Oncology CrossRef
  19. Deciphering roles of TRIMs as promising targets in hepatocellular carcinoma: current advances and future directions
    Jie Zhang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  20. TRIM58 inactivates p53/p21 to promote chemoresistance via ubiquitination of DDX3 in breast cancer
    Juan Wang et al, 2022, The International Journal of Biochemistry & Cell Biology CrossRef
  21. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma
    Koichiro Kajiura et al, 2017, Oncotarget CrossRef
  22. Alteration in DNA methylation patterns: Epigenetic signatures in gastrointestinal cancers
    Zahra Heydari et al, 2024, European Journal of Pharmacology CrossRef
  23. Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy
    Zheng Wang et al, 2022, Frontiers in Immunology CrossRef